A Phase 1 Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of AS-S603 in Healthy Participants

NCT06786676 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: AS-S603
DRUG: Placebo

Sponsor

Amyloid Solution Inc